AME vs EBS
Ametek Inc (AME) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
Ametek Inc (AME) is a specialty industrial machinery company listed on US.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported AME revenue for 2024-12-31 was $6.94B. Net income was $1.38B. Revenue was up 5.2% from 2023-12-31 to 2024-12-31. AME currently screens at market cap $42.11B and trailing P/E 29.9.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
AME currently screens at market cap $42.11B and trailing P/E 29.9. EBS currently screens at market cap $416.4M.
Not investment advice. Open the AME and EBS stock pages for the full models.
Not investment advice.